Bridgecreek Investment Management, LLC Bausch Health Companies Inc. Transaction History

Bridgecreek Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 01, 2020	SELL	$12.98 - $30.25 $4.49 Million - $10.5 Million	-345,800 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$18.89 - $31.89 $155,370 - $262,295	-8,225 Reduced 2.32%	345,800 $10.3 Million
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $54,288 - $66,716	2,600 Added 0.74%	354,025 $7.74 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $35,397 - $45,626	1,725 Added 0.49%	351,425 $8.86 Million
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $238,714 - $310,222	11,800 Added 3.49%	349,700 $8.64 Million

Q4 2018 Feb 12, 2019	SELL	$17.64 - $28.32 $477,162 - $766,056	-27,050 Reduced 7.41%	337,900 $6.24 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $7.53 Million - $9.37 Million	364,950 New	364,950 $9.37 Million

282

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.62B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Bridgecreek Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgecreek Investment Management, LLC with notifications on news.